EDUCATION SESSION #809
Disruptive Innovation - Seeking Tomorrow's Success Stories
|
|
We are on the cusp of an epic tech cycle that is transforming every industry. In healthcare, unprecedented scientific advancements are leading to drugs that are changing the standard of care. Shifts in consumer preferences are impacting retailers, while electronic and autonomous vehicles are on pace to displace traditional autos and so much more!
Join us for an in-depth discussion with representatives across diverse industries on how they are embracing technological disruptions and what exciting opportunities lie in the future of their respective industries.
|
|
6:00 PM Registration
6:30 PM Event Begins
|
We will begin
promptly
at
6:30 PM
; please arrive early. Since it is disruptive to everyone when latecomers enter the session, those arriving after the event has begun will only be admitted at the discretion of 100WF and the host. Please note the start time on this invite and plan to arrive early.
|
Networking reception will follow.
|
Wellington Management International LTD
Cardinal Place
80 Victoria Street
London
, SW1E 5JL, United Kingdom
|
|
Helen Brand, CFA
UBS
Bahija Jallal
MedImmune and AstraZeneca
Anita Killian, CFA
Wellington Management
Irena Kyuchukova, CFA
Moderator
Wellington Management
|
|
If you have any questions about this event, please contact the
London Education
committee.
Visit your
Member Profile RSVPs
to confirm your event registration.
If you have no-show fees or access fees due, the system cannot register you for an event. You can view and pay for any outstanding fees on your
Member Profile
. If you have any membership questions, please contact the
Membership Committee
.
|
|
Helen Brand, CFA
Executive Director, UBS
Helen Brand is an Executive Director leading the coverage of European Luxury at UBS. She was ranked 4th in the Institutional Investor survey this year having joined the firm in 2015 from Barclays' luxury team (2010-2015). She started in 2006 with Lehman Brothers/Nomura in Consumer Retail M&A and Equity Research. She is CFA qualified and holds a 1st class degree (BSc) in Mathematics Operational Research Statistics and Economics from the University of Warwick.
Bahija Jallal
President, MedImmune and Executive Vice President, AstraZeneca
Dr. Bahija Jallal is President of MedImmune, the global biologics research and development unit of AstraZeneca. She is also Executive Vice President of AstraZeneca and is a member of its senior executive team reporting to the CEO. Dr. Jallal joined MedImmune in March 2006. Dr. Jallal serves on the Board of Anthem, Inc. and is a member of the Board of Trustees of the Johns Hopkins University and the Board of Directors of the University of Maryland Health Sciences Research Park Corporation. Dr. Jallal has authored over 70 peer-reviewed publications and has more than 15 patents. She is a member of the American Association of Cancer Research and the American Association of Science. She is also the President of the Association of Women in Science. Last year, Dr. Jallal was named the 2017 Woman of the Year by the Healthcare Businesswomen’s Association.
Anita Killian, CFA
Senior Managing Director, Partner and Global Industry Analyst, Wellington Management
Anita is focused on Asian technology stocks across all subsectors. She conducts fundamental analysis on companies and makes buy/sell recommendations to portfolio managers based on her findings and market conditions. She is also portfolio manager of a dedicated Asia Technology Fund. Prior to joining Wellington Management in 2000, Anita was an equity analyst with VALUEQUEST/TA, covering the telecom and technology sectors (1997 – 2000). She began her professional career at the Massachusetts Institute of Technology in both academic and administrative capacities (1987 – 1997). Anita received both her MS in earth and planetary sciences (1987) and her BS in physics from the Massachusetts Institute of Technology (1985). She also holds the Chartered Financial Analyst designation.
Irena Kyuchukova, CFA
Managing Director and Fixed Income Investment Director, Wellington Management
As an investment director in Fixed Income Product Management, Irena works closely with investment teams to help ensure the integrity of the investment approaches in her coverage. This includes meeting with the team on a regular basis and providing analysis of portfolio positioning, performance, and risk exposures. Irena contributes to developing new products and client solutions and managing business issues such as capacity, fees, and guidelines. She also participates in meetings with clients, prospects, and consultants to communicate our investment philosophy, strategy, positioning, and performance. Prior to joining Wellington Management in 2012, Irena worked as a credit trader at Morgan Stanley in both New York and London (2008 – 2012). Irena earned a BA in economics and mathematics, summa cum laude, from Dartmouth College (2008). Additionally, she holds the Chartered Financial Analyst designation.
|
|
Wellington Management
Tracing our history to 1928,
Wellington Management
is one of the world’s largest independent investment management firms. With US$1,078 billion in assets under management as of 31 March 2018, we serve as a trusted adviser to institutional clients and mutual fund sponsors in over 60 countries. Our innovative investment solutions are built on the strength of rigorous, proprietary research and span nearly all segments of the global capital markets, including equity, fixed income, multi-asset, and alternative strategies. As a private partnership whose sole business is investment management, our long-term views and interests are aligned with those of our clients. We seek to maintain a talented and diverse workforce and to foster an open, collaborative culture of inclusivity, because we believe multiple perspectives lead to more informed investment and business decisions. We welcome people with diverse life experiences, fresh ideas, and specialized subject-matter expertise.
Wellington is a proud member of 100 Women in Finance’s
Leadership Council
. 100WF Leadership Council is a select group of international banks, alternative investment firms, asset management firms and others in the industry who support the long run mission of 100 Women in Finance.
|
|
100 Women in Finance
100 Women in Finance
is a global network of professionals in the finance and alternative investment industries working together to empower women at every stage of their careers. Through peer engagement, philanthropic, and educational initiatives, our more than 15,000 members are making connections and creating opportunities that help to advance careers and strengthen our field.
|
|
This event is
NOT FOR ATTRIBUTION
. All 100WF events are private events and we require that no one reports publicly on any aspect of them
.
Admission is free, but there is a £20 charge if you register and do not attend, even if you cancel in advance. Latecomers may also be subject to the fee at the discretion of the event hosts and organizers. No-show proceeds will be donated to the beneficiary of 100WF's most recent UK philanthropic initiatives.
Space is limited. No walk-ins will be permitted.
100WF Profile Update
Is your profile up to date? If not, we encourage you to update your
Member Profile
to ensure that you are receiving By Invite Only event invitations and job opportunities, among other targeted and special emails.
100WF Access Fee
Have you paid your access fee? If not please go to
100WF Member Payment
. We appreciate your continued support!
|
|
Please do not reply to this email.
If you have any questions about this event, please contact us at the link shown above or visit our website at
www.100women.org
You received this email because of your interest in 100 Women in Finance. You can update your email preferences and unsubscribe using the SafeUnsubscribe link below. If you are registered as a 100WF Member or Supporter you can update your
registration details
, change your
email preferences
or
unsubscribe
by logging into your
Member Profile
.
|
|
|
|
|
|
|
